Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Beheshti M et al. – Positron emission tomography is increasing in popularity for staging newly diagnosed prostate cancer and for assessing response to therapy. Many positron emission tomography tracers have been tested for use in the evaluation of prostate cancer patients based on increased glycolysis, cell membrane proliferation by radiolabeled phospholipids, fatty acid synthesis, amino acid transport and protein synthesis, androgen receptor expression, and osteoblastic activity.


Today in Oncology...keeping you current

Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

What comes after docetaxel
Der Urologe, 11/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address